Latest Market News

Page 557 of 2010
Algorae Pharmaceuticals has locked in a $3 million revolving debt facility with ScotPac, providing flexible, non-dilutive funding to accelerate its commercial operations across Australia and New Zealand.
Victor Sage
Victor Sage
21 Jan 2026
Noxopharm has successfully completed the final multiple-dose cohort of its HERACLES trial for SOF-SKN™, reporting no significant safety concerns and paving the way for Phase II-enabling studies.
Ada Torres
Ada Torres
21 Jan 2026
Energy Fuels Inc. has announced a proposed acquisition of Australian Strategic Materials (ASM) valued at approximately A$447 million, aiming to establish a leading Western rare earths and critical minerals producer with a fully integrated supply chain.
Maxwell Dee
Maxwell Dee
21 Jan 2026
Energy Fuels Inc. has announced a binding agreement to acquire Australian Strategic Materials Ltd (ASM) in a deal valuing ASM at approximately A$447 million, offering shareholders a 121% premium. The acquisition aims to establish a vertically integrated Western rare earths supply chain, aligning with critical minerals strategies between the US and Australia.
Maxwell Dee
Maxwell Dee
21 Jan 2026
Barton Gold Holdings reports final Phase 1 drilling results from its Tunkillia Gold Project, revealing shallow, high-grade gold intersections that underpin a $1.3 billion operating profit forecast. The company is set to commence Phase 2 drilling and advance towards a Mining Lease application in 2026.
Maxwell Dee
Maxwell Dee
21 Jan 2026
Tivan Limited has made significant strides in its critical minerals portfolio, securing a $51.3 million strategic investment and progressing key feasibility studies across multiple projects.
Maxwell Dee
Maxwell Dee
21 Jan 2026
BCAL Diagnostics has launched its Avantect pancreatic and ovarian cancer tests in Australia, alongside expanding clinical data and establishing a national registry for its BREASTESTplus breast cancer test.
Ada Torres
Ada Torres
21 Jan 2026
AdAlta Limited has aligned its AdCella manufacturing strategy with new US FDA guidelines, made a significant milestone payment to Shanghai Cell Therapy Group, and secured an additional R&D tax rebate, marking key progress in its cellular immunotherapy pipeline.
Ada Torres
Ada Torres
21 Jan 2026
Vulcan Energy has reported strong production test results from its LSC-1b sidetrack well, reinforcing the viability of its Phase One Lionheart lithium project in Germany. The well’s performance supports the project’s ambitious lithium and renewable energy production targets.
Maxwell Dee
Maxwell Dee
21 Jan 2026
Aurelia Metals reports a strong December quarter with production ramp-ups ahead of schedule at Federation Mine and robust progress across its Peak and Great Cobar projects, underpinning solid cash flow and a healthy balance sheet.
Maxwell Dee
Maxwell Dee
21 Jan 2026
Anteris Technologies has launched a $200 million public offering alongside a $90 million strategic investment from Medtronic, aiming to accelerate its DurAVR heart valve clinical trials and manufacturing expansion.
Ada Torres
Ada Torres
21 Jan 2026
Lynas Rare Earths reported a 43% year-on-year revenue increase to A$201.9 million in Q2 FY26 despite a 30% drop in key NdPr production due to power disruptions and maintenance. The company also announced CEO Amanda Lacaze’s planned retirement at year-end.
Maxwell Dee
Maxwell Dee
21 Jan 2026